InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Browse the detailed record of transactions filed by Mazumdar-Shaw Kiran. Officer active across 1 company, notably Bicara Therapeutics Inc.. Aggregated, 1 disclosures have been published. History available since 16 September 2024. The latest transaction was filed on 16 September 2024 (C). Regulator: SEC (Form 4). The full history is free.
1 of 1 declaration